What Happened? Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

As previously reported, Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral with a price target of $71, up from $62, citing ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS Health ended 2024 as it started, with high medical costs in the company’s insurance business chipping away at its bottom ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

U.S. stocks pared early losses on Wednesday but remained mostly lower after inflation data came in hotter than expected, potentially complicating the Federal Reserve's job of returning inflation to ...

CVS Health plans to shed enrollment by more than 1 million members this year, mostly in Medicare Advantage and individual ...

When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.

CVS, which operates the nation's largest pharmacy chain, health insurer Aetna, and the pharmacy benefit manager Caremark, beat estimates on the top and bottom lines in the fourth quarter. Revenue rose ...